Two years after pandemic influenza A/2009/H1N1: what have we learned?
about
Amantadine and rimantadine for influenza A in children and the elderlyCorticosteroids as adjunctive therapy in the treatment of influenzaInfluenza treatment and prophylaxis with neuraminidase inhibitors: a reviewConnecting the study of wild influenza with the potential for pandemic diseaseThe Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized MiceApproved Antiviral Drugs over the Past 50 YearsOne health, multiple challenges: The inter-species transmission of influenza A virusAvian influenza A H5N1 virus: a continuous threat to humans.The value of radiographic findings for the progression of pandemic 2009 influenza A/H1N1 virus infection.Serological response of patients with influenza A (H1N1) pdm09-associated pneumonia: an observational study.Impact of 2009 pandemic influenza among Vietnamese children based on a population-based prospective surveillance from 2007 to 2011Preexisting CD4+ T-cell immunity in human population to avian influenza H7N9 virus: whole proteome-wide immunoinformatics analyses.Polymorphisms at residue 222 of the hemagglutinin of pandemic influenza A(H1N1)pdm09: association of quasi-species to morbidity and mortality in different risk categoriesOutcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studiesIntegrative analysis of differentially expressed microRNAs of pulmonary alveolar macrophages from piglets during H1N1 swine influenza A virus infectionMapMyFlu: visualizing spatio-temporal relationships between related influenza sequencesPhylogeography of Influenza A(H3N2) Virus in Peru, 2010-2012.Human H7N9 virus induces a more pronounced pro-inflammatory cytokine but an attenuated interferon response in human bronchial epithelial cells when compared with an epidemiologically-linked chicken H7N9 virus.Cross-immunity Against Avian Influenza A(H7N9) Virus in the Healthy Population Is Affected by Antigenicity-Dependent Substitutions.Additional molecular testing of saliva specimens improves the detection of respiratory viruses.A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses.Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseActivation mechanisms of natural killer cells during influenza virus infectionCryptoporus volvatus extract inhibits influenza virus replication in vitro and in vivoPrognosis of 18 H7N9 avian influenza patients in Shanghai.Can newly developed, rapid immunochromatographic antigen detection tests be reliably used for the laboratory diagnosis of influenza virus infections?Virological characterization of influenza H1N1pdm09 in Vietnam, 2010-2013.Risk factors associated with mortality in patients infected with influenza A/H1N1 in Mexico.Toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB/c mice.A review of neuraminidase inhibitor susceptibility in influenza strains.Factors Associated with Lethal Outcome in Patients with Severe Form of Influenza.Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection.Immunogenicity of intradermal trivalent influenza vaccine with topical imiquimod: a double blind randomized controlled trial.Pathogenic influenza B virus in the ferret model establishes lower respiratory tract infection.Combined administration of oseltamivir and hochu-ekki-to (TJ-41) dramatically decreases the viral load in lungs of senescence-accelerated mice during influenza virus infection.Analytical sensitivity of seven point-of-care influenza virus detection tests and two molecular tests for detection of avian origin H7N9 and swine origin H3N2 variant influenza A virusesAssessment of antigen and molecular tests with serial specimens from a patient with influenza A(H7N9) infection.Dual-functional peptide with defective interfering genes effectively protects mice against avian and seasonal influenza.Computed tomography findings in patients with H1N1 influenza A infectionHeterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses
P2860
Q24187883-05FFE00C-3482-42CF-A22F-59900D26F9FAQ24201063-2080DC60-D1B4-42A1-BC53-787EAC7B9523Q26860032-D425CBAA-7882-4876-A87F-B3F4B9258F27Q27027237-B1C7319E-09BB-46BF-A631-6486DA96AC82Q27322928-AB31C419-40D3-49DE-B573-63480225ABDAQ27755387-D2C700BF-F2ED-4A41-AAE5-569EEBCC5E36Q28386183-6E882A12-C78E-4891-A8D8-0BAA3A2A1ED0Q30224462-5088E7C8-0A0B-4EC8-BEFD-221D258E1559Q30355134-C8B7C7E0-3258-41E4-B82F-15B2946FDA2EQ30356492-5AF9EF4B-0970-4BBF-8D54-C92BD64EFCBCQ30359851-55AD2DA0-0CF4-48E3-838B-CC7FE93AAB22Q30359962-31E35132-C420-4207-92DF-F107203C80F4Q30360630-A7594C39-6596-4374-AAAF-B31D82CA2745Q30364474-D627C83B-D41F-442D-8785-C1F3A5DA9D77Q30371291-CC69E014-F48F-43EA-8BDD-E5D62D842DBEQ30374371-673A067C-FEB2-421B-ADFB-038A63E9D931Q30377005-44B246A8-DE37-4ADA-8D57-7602429ED4C5Q30385648-3A7A55BA-C3F8-4C40-AB44-BB3B02E8EC49Q30394072-F327E4DF-EEAA-47A4-B231-16DC88D4AB30Q30402787-010693DE-D28F-4F90-A2BA-B5EE13B517A7Q33910008-38981358-1958-405D-A14B-A590C0C1EBEEQ34468689-8AC39F27-E9F4-4B5C-95C8-65E73B763530Q34540276-98C0F022-9064-4F8C-A36B-A042531647CDQ34600066-27B54F45-E78A-4BFA-BEC4-BF13CFB7C666Q35138437-36BDF3BB-7455-4C65-9577-4300CE1280C7Q35607432-4CC88E9B-0B1C-48E2-A261-558AA2EA1323Q35761077-77851077-94E1-4E91-9288-7A3E17C6BA43Q35771451-653ABB7B-5B3E-4F24-A15D-4558AE2A43E3Q37712843-FC61542A-E1D9-4081-ABD0-594BCBD59180Q38258646-B8810B5C-3759-41D8-82DA-CF357C29D3C5Q39156558-C6603D99-D0F1-4D79-AF8C-ABB9BB921296Q41524622-A9FDF77E-6CCE-4D05-87FF-002673176D25Q42204647-E36451A6-3A35-4D9D-A247-F114176C1CD9Q42208634-0B8DCAD0-C184-4A7F-A720-5B4C114A98C2Q42274102-745A45CD-635D-43FE-AF0F-14A16C3C5B63Q42573523-9CCC76F3-D6D2-4798-9534-EE750DB60318Q42619066-3A16B0D8-F400-4128-BD9F-68227BF708DBQ55317717-C3486566-205C-4369-A036-F98DBB370684Q56765042-187DC6DD-4EA5-4AC6-AB55-BEA2E4D92352Q56975792-8732E2A4-CF33-403E-AA75-D16791079CCA
P2860
Two years after pandemic influenza A/2009/H1N1: what have we learned?
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Two years after pandemic influenza A/2009/H1N1: what have we learned?
@ast
Two years after pandemic influenza A/2009/H1N1: what have we learned?
@en
type
label
Two years after pandemic influenza A/2009/H1N1: what have we learned?
@ast
Two years after pandemic influenza A/2009/H1N1: what have we learned?
@en
prefLabel
Two years after pandemic influenza A/2009/H1N1: what have we learned?
@ast
Two years after pandemic influenza A/2009/H1N1: what have we learned?
@en
P2860
P50
P356
P1476
Two years after pandemic influenza A/2009/H1N1: what have we learned?
@en
P2093
Herman Tse
Vincent C C Cheng
P2860
P304
P356
10.1128/CMR.05012-11
P407
P577
2012-04-01T00:00:00Z